Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil with remimazolam for bronchoscopy in elderly patients
ChiCTR2600116232Phase 4Not yet recruiting
- Sponsor
- People's Hospital of Qiannan
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in Chest diseases (2 arms), sponsored by People's Hospital of Qiannan. Primary endpoint: Cough and body movement score. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
Chest diseases
Beyond the preview
Go deeper on ChiCTR2600116232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116232.